Duloxetine 30 MG
Duloxetine 30 MG is a pharmaceutical drug with 9 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
4
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Identifying and Treating Depression in the Orthopaedic Trauma Population
Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures
Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough
Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain
Clinical Trials (9)
Identifying and Treating Depression in the Orthopaedic Trauma Population
Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures
Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough
Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain
Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)
The Effect of Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Fibromyalgia
Efficacy of Duloxetine Compared to NSIADs in Osteoarthritis of Knee
Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer Patients
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9